Recall alert: 13K bottles of blood pressure medication recalled - WSB-TV
The FDA has issued a nationwide recall for over 13,000 bottles of Chlorthalidone blood pressure medication following failed dissolution testing.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
The FDA issued a nationwide recall for more than 13,000 bottles of a common blood pressure medication. The recall was upgraded after the medication failed FDA dissolution testing.
Epilogue added 48d ago, after coverage quieted.
The brief
A nationwide recall has been initiated for a common blood pressure medication, affecting more than 13,000 bottles. Specifically, Medical Daily reports that 13,567 bottles of Chlorthalidone are being pulled from circulation. This action follows reports that the medication failed FDA dissolution testing, a critical quality standard for how the drug breaks down in the body. The recall is described by various sources as urgent, prompting alerts for patients to check their medicine cabinets for the affected medication. Coverage of the event is widespread across multiple media platforms. The Healthy, NTD News, and WSB-TV focused on the scale of the recall, highlighting the thousands of bottles involved.
Yahoo, Yahoo News Singapore, and WBIR have reported on the FDA's role in the announcement and the fact that the medication failed specific dissolution tests. Additionally, The Sun reports that the FDA has upgraded the recall status of these medications, which are distributed across the United States. This current event is part of a larger pattern of quality issues with this specific medication. According to Medical Daily, this represents the second recall of Chlorthalidone within a three-month period. The recurrence of these recalls suggests ongoing challenges with the production or stability of this common blood pressure pill. Because the medication is used to manage hypertension, the FDA's decision to upgrade and announce the recall nationwide reflects the potential risks associated with medications that do not meet dissolution standards.
Moving forward, the focus remains on the nationwide distribution of the affected batches. Patients are encouraged to monitor their current supplies as the FDA continues to manage the recall process. Coverage does not yet specify the exact lot numbers or the specific manufacturer involved, but the trend indicates an urgent push to remove the non-compliant bottles from the market. Further updates from the FDA regarding the upgrade of the recall status will be the primary point of interest for healthcare providers and patients.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 48d ago.
Quick answers
How many bottles of medication are affected?
According to Medical Daily, 13,567 bottles of Chlorthalidone are being recalled, while other sources cite more than 13,000 bottles.
Why was the medication recalled?
The recall was issued after the blood pressure medication failed FDA dissolution testing.
Is this the first time this medication has been recalled?
No, Medical Daily reports that this is the second Chlorthalidone recall occurring within a three-month window.
Coverage (11)
- Common Blood Pressure Medication Recalled Yahoo · 51d ago
- Blood pressure medication recalled nationwide after failing FDA dissolution testing WBIR · 51d ago
- FDA upgrades recall of blood pressure meds distributed nationwide the-sun.com · 51d ago
- FDA Announces New Nationwide Blood Pressure Medication Recall yahoo.com · 51d ago
- FDA Announces New Nationwide Blood Pressure Medication Recall Yahoo News Singapore · 51d ago
- CHECK YOUR CABINETS: The FDA has issued an urgent recall for bottles of popular blood pressure medication. facebook.com · 54d ago
- More Than 13,000 Bottles of Blood Pressure Medication Recalled Nationwide The Healthy · 55d ago
- Thousands of Bottles of Blood Pressure Medication Recalled Across US NTD News · 55d ago
- Second Chlorthalidone Recall in Three Months Pulls 13,567 More Bottles of a Common Blood Pressure Pill Nationwide medicaldaily.com · 55d ago
- Major Drug Recall Alerts Patients Nationwide DailyVoice.com · 55d ago
- Recall alert: 13K bottles of blood pressure medication recalled WSB-TV · 55d ago
Topics
Related trends
Roche Secures First U.S. Approval for New Breast-Cancer Pill
Roche wins FDA approval for its first U.S. oral SERD, giredestrant plus everolimus, for hormone-resistant advanced breast cancer.
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Novo Nordisk reports Wegovy injection reduced BMI and obesity rates in children as young as six in a clinical trial, expanding the drug's potential pediatric use.
The GLP-1 boom has a dark side
FDA orders new eye-risk warnings on a dozen GLP-1 drugs, including Ozempic and Zepbound, amid reports of vision-threatening events.
Millions of Americans are not taking their GLP-1 drugs as prescribed
Nearly half of U.S. GLP-1 users are altering prescribed dosing, with cost and side effects driving widespread non-adherence.
FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class
The United States Food and Drug Administration has rejected Summit Therapeutics and Akeso's lung cancer drug ivonescimab.
New drug could be cure for common cause of high blood pressure
EU medicines panel recommends AstraZeneca's baxdrostat for uncontrolled hypertension, while new research suggests a potential cure for hormone-driven high blood pressure.